JP4300293B2 - Fluorine-containing unsaturated thiol derivative - Google Patents
Fluorine-containing unsaturated thiol derivative Download PDFInfo
- Publication number
- JP4300293B2 JP4300293B2 JP2004048437A JP2004048437A JP4300293B2 JP 4300293 B2 JP4300293 B2 JP 4300293B2 JP 2004048437 A JP2004048437 A JP 2004048437A JP 2004048437 A JP2004048437 A JP 2004048437A JP 4300293 B2 JP4300293 B2 JP 4300293B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- fluorine
- carbon
- synthesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229910052731 fluorine Inorganic materials 0.000 title claims description 20
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 title claims description 17
- 239000011737 fluorine Substances 0.000 title claims description 17
- 125000003396 thiol group Chemical class [H]S* 0.000 title claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 54
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 51
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- 150000001875 compounds Chemical class 0.000 description 37
- 239000000243 solution Substances 0.000 description 26
- 239000000203 mixture Substances 0.000 description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 16
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 16
- 238000004440 column chromatography Methods 0.000 description 16
- 239000000741 silica gel Substances 0.000 description 16
- 229910002027 silica gel Inorganic materials 0.000 description 16
- 238000003786 synthesis reaction Methods 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- 238000001914 filtration Methods 0.000 description 14
- 125000000962 organic group Chemical group 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 150000003573 thiols Chemical class 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000004293 19F NMR spectroscopy Methods 0.000 description 8
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 7
- 238000000806 fluorine-19 nuclear magnetic resonance spectrum Methods 0.000 description 7
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 7
- 229910052717 sulfur Inorganic materials 0.000 description 7
- -1 1-methylpentyl Chemical group 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 125000004434 sulfur atom Chemical group 0.000 description 6
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 229940126214 compound 3 Drugs 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 4
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229940125797 compound 12 Drugs 0.000 description 4
- 229920001542 oligosaccharide Polymers 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 3
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229940126657 Compound 17 Drugs 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- WREOTYWODABZMH-DTZQCDIJSA-N [[(2r,3s,4r,5r)-3,4-dihydroxy-5-[2-oxo-4-(2-phenylethoxyamino)pyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N(C=C\1)C(=O)NC/1=N\OCCC1=CC=CC=C1 WREOTYWODABZMH-DTZQCDIJSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 229940125758 compound 15 Drugs 0.000 description 3
- 229940126142 compound 16 Drugs 0.000 description 3
- 229940125898 compound 5 Drugs 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000002777 nucleoside Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 3
- 238000000527 sonication Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 2
- PAJPWUMXBYXFCZ-UHFFFAOYSA-N 1-aminocyclopropanecarboxylic acid Chemical compound OC(=O)C1(N)CC1 PAJPWUMXBYXFCZ-UHFFFAOYSA-N 0.000 description 2
- JYWKEVKEKOTYEX-UHFFFAOYSA-N 2,6-dibromo-4-chloroiminocyclohexa-2,5-dien-1-one Chemical compound ClN=C1C=C(Br)C(=O)C(Br)=C1 JYWKEVKEKOTYEX-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000001414 amino alcohols Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- LLCSWKVOHICRDD-UHFFFAOYSA-N buta-1,3-diyne Chemical group C#CC#C LLCSWKVOHICRDD-UHFFFAOYSA-N 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002337 glycosamines Chemical class 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 239000003317 industrial substance Substances 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- LDDMACCNBZAMSG-BDVNFPICSA-N (2r,3r,4s,5r)-3,4,5,6-tetrahydroxy-2-(methylamino)hexanal Chemical compound CN[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO LDDMACCNBZAMSG-BDVNFPICSA-N 0.000 description 1
- IRJCBFDCFXCWGO-BYPYZUCNSA-N (2s)-2-amino-2-(3-oxo-1,2-oxazol-5-yl)acetic acid Chemical compound OC(=O)[C@@H](N)C1=CC(=O)NO1 IRJCBFDCFXCWGO-BYPYZUCNSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- UVNPEUJXKZFWSJ-LMTQTHQJSA-N (R)-N-[(4S)-8-[6-amino-5-[(3,3-difluoro-2-oxo-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-yl]-2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@@](=O)N[C@@H]1COCC11CCN(CC1)c1cnc(Sc2ccnc3NC(=O)C(F)(F)c23)c(N)n1 UVNPEUJXKZFWSJ-LMTQTHQJSA-N 0.000 description 1
- KWXGJTSJUKTDQU-UHFFFAOYSA-N 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-heptadecafluoro-8-iodooctane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)I KWXGJTSJUKTDQU-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- BXRLWGXPSRYJDZ-UHFFFAOYSA-N 3-cyanoalanine Chemical compound OC(=O)C(N)CC#N BXRLWGXPSRYJDZ-UHFFFAOYSA-N 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 1
- 229940000681 5-hydroxytryptophan Drugs 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N 6-methyloxane-2,3,4,5-tetrol Chemical compound CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- GMXIEASXPUEOTG-UHFFFAOYSA-N 8-bromooctan-1-ol Chemical compound OCCCCCCCCBr GMXIEASXPUEOTG-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- AVGPOAXYRRIZMM-UHFFFAOYSA-N D-Apiose Natural products OCC(O)(CO)C(O)C=O AVGPOAXYRRIZMM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- ASNHGEVAWNWCRQ-LJJLCWGRSA-N D-apiofuranose Chemical compound OC[C@@]1(O)COC(O)[C@@H]1O ASNHGEVAWNWCRQ-LJJLCWGRSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N D-apiofuranose Natural products OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- ZGVNGXVNRCEBDS-UHFFFAOYSA-N D-hamamelose Natural products OCC(O)C(O)C(O)(CO)C=O ZGVNGXVNRCEBDS-UHFFFAOYSA-N 0.000 description 1
- HAIWUXASLYEWLM-UHFFFAOYSA-N D-manno-Heptulose Natural products OCC1OC(O)(CO)C(O)C(O)C1O HAIWUXASLYEWLM-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical group O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-OBAJZVCXSA-N Gentianose Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@H](O)[C@@H](CO)O2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-OBAJZVCXSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- IRJCBFDCFXCWGO-UHFFFAOYSA-N Ibotenic acid Natural products OC(=O)C(N)C1=CC(=O)NO1 IRJCBFDCFXCWGO-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FSBIGDSBMBYOPN-VKHMYHEASA-N L-canavanine Chemical compound OC(=O)[C@@H](N)CCONC(N)=N FSBIGDSBMBYOPN-VKHMYHEASA-N 0.000 description 1
- HSNZZMHEPUFJNZ-UHFFFAOYSA-N L-galacto-2-Heptulose Natural products OCC(O)C(O)C(O)C(O)C(=O)CO HSNZZMHEPUFJNZ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- WZNJWVWKTVETCG-YFKPBYRVSA-N L-mimosine Chemical compound OC(=O)[C@@H](N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- NUGPIZCTELGDOS-QHCPKHFHSA-N N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclopentanecarboxamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CC[C@@H](C=1C=NC=CC=1)NC(=O)C1CCCC1)C NUGPIZCTELGDOS-QHCPKHFHSA-N 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- FSBIGDSBMBYOPN-UHFFFAOYSA-N O-guanidino-DL-homoserine Natural products OC(=O)C(N)CCON=C(N)N FSBIGDSBMBYOPN-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- HAIWUXASLYEWLM-AZEWMMITSA-N Sedoheptulose Natural products OC[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@](O)(CO)O1 HAIWUXASLYEWLM-AZEWMMITSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- VLSMHEGGTFMBBZ-UHFFFAOYSA-N alpha-Kainic acid Natural products CC(=C)C1CNC(C(O)=O)C1CC(O)=O VLSMHEGGTFMBBZ-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- LPZIZDWZKIXVRZ-KVTDHHQDSA-N beta-D-hamamelose Chemical compound OC[C@]1(O)[C@H](O)OC[C@@H](O)[C@H]1O LPZIZDWZKIXVRZ-KVTDHHQDSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000000842 betacyanins Nutrition 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 125000005066 dodecenyl group Chemical group C(=CCCCCCCCCCC)* 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- VZFRNCSOCOPNDB-AJKFJWDBSA-N domoic acid Chemical compound OC(=O)[C@@H](C)\C=C\C=C(/C)[C@H]1CN[C@H](C(O)=O)[C@H]1CC(O)=O VZFRNCSOCOPNDB-AJKFJWDBSA-N 0.000 description 1
- VZFRNCSOCOPNDB-UHFFFAOYSA-N domoic acid Natural products OC(=O)C(C)C=CC=C(C)C1CNC(C(O)=O)C1CC(O)=O VZFRNCSOCOPNDB-UHFFFAOYSA-N 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- MUPFEKGTMRGPLJ-WSCXOGSTSA-N gentianose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-WSCXOGSTSA-N 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000002386 heptoses Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- OOJZCXFXPZGUBJ-RITPCOANSA-N hypoglycin Chemical compound OC(=O)[C@@H](N)C[C@H]1CC1=C OOJZCXFXPZGUBJ-RITPCOANSA-N 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- VZFRNCSOCOPNDB-OXYNIABMSA-N isodomoic acid D Natural products CC(C=C/C=C(/C)C1CNC(C1CC(=O)O)C(=O)O)C(=O)O VZFRNCSOCOPNDB-OXYNIABMSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- GJRGEVKCJPPZIT-UHFFFAOYSA-N isomugineic acid Natural products OC(=O)C(O)CCNC(C(O)=O)C(O)CN1CCC1C(O)=O GJRGEVKCJPPZIT-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- VLSMHEGGTFMBBZ-OOZYFLPDSA-N kainic acid Chemical compound CC(=C)[C@H]1CN[C@H](C(O)=O)[C@H]1CC(O)=O VLSMHEGGTFMBBZ-OOZYFLPDSA-N 0.000 description 1
- 229950006874 kainic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- ARNWQMJQALNBBV-UHFFFAOYSA-N lithium carbide Chemical compound [Li+].[Li+].[C-]#[C-] ARNWQMJQALNBBV-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 229950002289 mimosine Drugs 0.000 description 1
- GJRGEVKCJPPZIT-JBDRJPRFSA-N mugineic acid Chemical compound OC(=O)[C@@H](O)CCN[C@H](C(O)=O)[C@@H](O)CN1CC[C@H]1C(O)=O GJRGEVKCJPPZIT-JBDRJPRFSA-N 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005069 octynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- HSNZZMHEPUFJNZ-SHUUEZRQSA-N sedoheptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-SHUUEZRQSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- NMHIUKCEPXGTRP-HCWXCVPCSA-N streptose Chemical compound C[C@H](O)[C@](O)(C=O)[C@@H](O)C=O NMHIUKCEPXGTRP-HCWXCVPCSA-N 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000005065 undecenyl group Chemical group C(=CCCCCCCCCC)* 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Images
Description
本発明は、界面活性剤またはその合成中間体等として利用される新規な含フッ素化合物に関するものである。 The present invention relates to a novel fluorine-containing compound used as a surfactant or a synthetic intermediate thereof.
一般に、ジアセチレン含有化合物は紫外線照射されると、より安定な共重合体を形成することが知られており、その一方の末端にカルボン酸、水酸基、チオール基などの官能基を有するジアセチレン化合物も合成されている。また、金表面の被膜には、チオールとジアセチレン結合を有する化合物が金表面の被膜として利用できることが報告されている(例えば、非特許文献1、特許文献1〜3参照)。
In general, diacetylene-containing compounds are known to form more stable copolymers when irradiated with ultraviolet rays, and diacetylene compounds having a functional group such as a carboxylic acid, a hydroxyl group, and a thiol group at one end thereof Has also been synthesized. In addition, it has been reported that a compound having a thiol and diacetylene bond can be used as a gold surface coating for the gold surface coating (see, for example,
また、Leeらは、F(CF2)m(CH2)nSH(m=1〜4、n=9〜15)の合成に成功しており、そのチオールを水酸基に置き換えた化合物も合成している。ところが、これらに炭素−炭素三重結合や二重結合を導入した化合物については未だ得られていない。同じく、Calasらも、F(CF2)m(CH2)nSH(m=6,8、n=2,11)とそのチオールを水酸基に置き換えた化合物の合成には成功しているものの、炭素−炭素三重結合や二重結合を導入したものは合成していない(非特許文献2〜3参照)。
Lee et al. Have also succeeded in synthesizing F (CF 2 ) m (CH 2 ) n SH (m = 1 to 4, n = 9 to 15), and synthesized a compound in which the thiol is replaced with a hydroxyl group. ing. However, a compound in which a carbon-carbon triple bond or a double bond is introduced into these has not been obtained yet. Similarly, Calas et al. Have succeeded in synthesizing a compound in which F (CF 2 ) m (CH 2 ) n SH (m = 6, 8, n = 2, 11) and its thiol are replaced with hydroxyl groups, A carbon-carbon triple bond or a double bond introduced is not synthesized (see
一方、Luらは、Rf−C≡C−RとRf−(CH=CH)2−Rで表される化合物の中で、RfはCl(CF2)n(n=2,4,8)、CF3及びC2F5
から選ばれる基と、Rはn−CnHm(n,m=3,7;5,11;6,13;8,17)及び(CH2)nOH(n=6,9)から選ばれる基との組合せからなる化合物を得たことを報告している(非特許文献4参照)が、チオール誘導体への変換には成功していない。
On the other hand, Lu et al., Among compounds represented by Rf—C≡C—R and Rf— (CH═CH) 2 —R, Rf is Cl (CF 2 ) n (n = 2, 4, 8). , CF 3 and C 2 F 5
R is selected from n-C n H m (n, m = 3, 7; 5, 11; 6, 13; 8, 17) and (CH 2 ) n OH (n = 6, 9). Although it has been reported that a compound composed of a combination with a selected group has been obtained (see Non-Patent Document 4), it has not been successfully converted into a thiol derivative.
さらに、Friedらは、プロスタグランジンの研究過程において、不安定なprostacyclin(PGI2)とthromboxane(TXA2)にフッ素原子を導入すると安定な構造を採るものと考えて、2分子の炭素−炭素三重結合または二重結合に挟まれたメチレン(CH2)をCF2 に置換した化合物を合成している(非特許文献5参照)が、CF2 以外のフッ素化合物の導入は行っていない。 Further, Fried et al. Considered that when a fluorine atom is introduced into unstable prostheclinin (PGI 2 ) and thromboxane (TXA 2 ) in the prostaglandin research process, a stable structure is assumed. A compound in which methylene (CH 2 ) sandwiched between triple bonds or double bonds is substituted with CF 2 is synthesized (see Non-Patent Document 5), but no fluorine compound other than CF 2 is introduced.
本発明の目的は、同一分子内に含フッ素有機基と炭素−炭素不飽和結合(二重結合または三重結合)と硫黄原子(SH、SまたはSS)を併せ有し、良好な界面活性能を有するかまたはその合成中間体として有用な新規化合物を提供することにある。 The object of the present invention is to have a fluorine-containing organic group, a carbon-carbon unsaturated bond (double bond or triple bond) and a sulfur atom (SH, S or SS) in the same molecule, and to have a good surface activity. It is to provide a novel compound having or useful as a synthesis intermediate thereof.
本発明者らは、前記課題の解決について鋭意研究を重ねた結果、1価の含フッ素有機基が炭素−炭素二重結合または三重結合の一端に結合し、他の一端に硫黄原子(SH、S、SS)を含む有機基の結合した化合物が比較的に高収率で得られることを見出し、本発明を完成させるに至った。 As a result of intensive research on solving the above problems, the present inventors have bonded a monovalent fluorine-containing organic group to one end of a carbon-carbon double bond or a triple bond, and a sulfur atom (SH, It has been found that an organic group-bonded compound containing S, SS) can be obtained in a relatively high yield, and the present invention has been completed.
すなわち、本発明によれば、同一分子内にフッ素原子と硫黄原子と炭素−炭素二重結合または三重結合とを有する、一般式(1)または(2)で表される含フッ素不飽和チオール誘導体が提供される。
R1-X-R2 (1)
R1-X-R3-S-S-R3-X-R1 (2)
[式中、R 1 は炭素数2〜25のパーフルオロアルキル基を、R 2 はSHを有する炭素数2〜25のアルキル基を、R 3 は炭素数2〜25のアルキレン基を、Xは、C≡Cまたは(CH=CH) n (ただし、n=2である。)を示す。]
That is, according to the present invention, the fluorine-containing unsaturated thiol derivative represented by the general formula (1) or (2) having a fluorine atom, a sulfur atom, and a carbon-carbon double bond or triple bond in the same molecule. Is provided.
R 1 -XR 2 (1)
R 1 -XR 3 -SSR 3 -XR 1 (2)
[Wherein R 1 represents a perfluoroalkyl group having 2 to 25 carbon atoms, R 2 represents an alkyl group having 2 to 25 carbon atoms having SH, R 3 represents an alkylene group having 2 to 25 carbon atoms, and X represents , C≡C or (CH═CH) n (where n = 2). ]
本発明によれば、同一分子内に含フッ素有機基と不飽和結合(二重結合または三重結合)と硫黄原子(SHまたはSSまたはS)を併有する新規化合物が提供される。
本発明方法の含フッ素不飽和チオール誘導体は、界面活性剤として有効であり、化粧品、農薬、工業薬品などに幅広く用いられ、また、多様な技術分野に利用される界面活性剤の合成中間体としても有用である。
According to the present invention, there is provided a novel compound having both a fluorine-containing organic group, an unsaturated bond (double bond or triple bond) and a sulfur atom (SH or SS or S) in the same molecule.
The fluorine-containing unsaturated thiol derivative of the method of the present invention is effective as a surfactant, widely used in cosmetics, agricultural chemicals, industrial chemicals, etc., and as a synthetic intermediate for surfactants used in various technical fields. Is also useful.
本発明の含フッ素不飽和チオール誘導体は、下記一般式(1)または一般式(2)で表すことができる。
R1-X-R2 (1)
R1-X-R3-S-S-R3-X-R1 (2)
上記一般式(1)または一般式(2)において、R 1 は炭素数2〜25のパーフルオロアルキル基を、R 2 はSHを有する炭素数2〜25のアルキル基を、R 3 は炭素数2〜25のアルキレン基を示す。
また、Xはアセチレン結合を示す炭素−炭素三重結合であるC≡Cまたはエチレン結合を示す炭素−炭素二重結合であるCH=CHを2個連続して有するものである。この二重結合の立体配置は、EまたはZのいずれの立体異性体であっても良く、さらに、S−シス配座またはS−トランス配座のいずれでも良い。さらに共役ジエンの場合、2つの二重結合がEE、EZ、ZZのいずれでも良く、さらに二重結合同士がS−シス配座またはS−トランス配座のいずれでも良い。
The fluorine-containing unsaturated thiol derivative of the present invention can be represented by the following general formula (1) or general formula (2).
R 1 -XR 2 (1)
R 1 -XR 3 -SSR 3 -XR 1 (2)
In the general formula (1) or (2), R 1 is a perfluoroalkyl group having 2 to 25 carbon atoms, R 2 is an alkyl group having 2 to 25 carbon atoms having SH, and R 3 is carbon number. 2 to 25 alkylene groups are shown.
Further, X has two consecutive C≡C, which is a carbon-carbon triple bond showing an acetylene bond, or CH═CH, which is a carbon-carbon double bond showing an ethylene bond. The configuration of this double bond may be any of the stereoisomers of E or Z, and may be either the S-cis conformation or the S-trans conformation. Further, in the case of a conjugated diene, the two double bonds may be any of EE, EZ, and ZZ, and the double bonds may be in either the S-cis conformation or the S-trans conformation.
本発明の含フッ素不飽和チオール誘導体において、前記R1〜R3に示されているそれぞれの有機基に含まれる炭素原子数は、2〜100、好ましくは50以下、より好ましくは25以下のものである。R1〜R3を構成する有機基には、以下に示す各種のものが包含される。
まず、脂肪族基としては、鎖状(分岐したものを含む)及び環状のものが包含され、さらに、飽和及び不飽和のものが包含される。鎖状脂肪族基には、アルキル基及びアルケニル基が包含される。環状脂肪族基には、シクロアルキル基及びシクロアルケニル基が包含される。アルキル基において、その主鎖を構成する炭素原子数は、好ましくは2〜60、より好ましくは2〜25である.アルケニル基において、その主鎖を構成する炭素数原子は、好ましくは2〜50、より好ましくは2〜25である.シクロアルキル基及びシクロアルケニル基において、その環数は1個又は複数個(2〜4個、好ましくは2〜3個)であることができる。その分子を構成する炭素原子数は5〜60、好ましくは6〜25である。
In the fluorine-containing unsaturated thiol derivative of the present invention, the number of carbon atoms contained in each organic group represented by R 1 to R 3 is 2 to 100, preferably 50 or less, more preferably 25 or less. It is. The organic groups constituting R 1 to R 3 include various types shown below.
First, the aliphatic group includes chain (including branched) and cyclic groups, and further includes saturated and unsaturated groups. The chain aliphatic group includes an alkyl group and an alkenyl group. Cycloaliphatic groups include cycloalkyl groups and cycloalkenyl groups. In the alkyl group, the number of carbon atoms constituting the main chain is preferably 2 to 60, more preferably 2 to 25. In the alkenyl group, the number of carbon atoms constituting the main chain is preferably 2 to 50, more preferably 2 to 25. In the cycloalkyl group and the cycloalkenyl group, the number of rings can be one or more (2 to 4, preferably 2 to 3). The number of carbon atoms constituting the molecule is 5 to 60, preferably 6 to 25.
前記有機基の具体例としては、例えば、エチル、n−プロピル、イソプロピル、n−ブチル、イソブチル、sec−ブチル、t−ブチル、n−ペンチル、イソペンチル、2−メチルブチル、1−メチルブチル、n−へキシル、イソヘキシル、3−メチルペンチル、2−メチルペンチル、1−メチルペンチル、ヘプチル、オクチル、イソオクチル、2−エチルヘキシル、ノニル、デシル、ウンデシル、ドデシル、テトラデシル、ヘキサデシル、オタタデシル、エイコシル、シクロペンチル、シクロへキシル、アダマンチル、ビニル、プロペニル、ブテニル、アクリル、メタクリル、オクチニル、ドデセニル、ウンデセニル、シクロヘキセニルなどが挙げられる。 Specific examples of the organic group include, for example, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t-butyl, n-pentyl, isopentyl, 2-methylbutyl, 1-methylbutyl, and n-to. Xyl, isohexyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, heptyl, octyl, isooctyl, 2-ethylhexyl, nonyl, decyl, undecyl, dodecyl, tetradecyl, hexadecyl, otatadecyl, eicosyl, cyclopentyl, cyclohexyl , Adamantyl, vinyl, propenyl, butenyl, acrylic, methacryl, octynyl, dodecenyl, undecenyl, cyclohexenyl and the like.
これらの有機基には、本発明の合成反応に関与しない不活性な置換基を有していてもよく、このような置換基としては、置換あるいは未置換アリール基、カルボニル基、アルコキシ基、アルコキシカルボニル基、アシル基、アシルオキシ基、アルキルまたはアリールスルホニル基、ニトロ基、ハロゲン(フッ素原子、塩素原子、臭素原子、よう素原子)等が包含される。 These organic groups may have an inert substituent that does not participate in the synthesis reaction of the present invention. Examples of such a substituent include a substituted or unsubstituted aryl group, a carbonyl group, an alkoxy group, an alkoxy group. Examples include carbonyl group, acyl group, acyloxy group, alkyl or arylsulfonyl group, nitro group, halogen (fluorine atom, chlorine atom, bromine atom, iodine atom) and the like.
また、前記有機基は、その有機基の主鎖中に異種原子(へテロ原子)を含有することができる。異種原子には、酸素原子、窒素原子、イオウ原子、ケイ素原子等が包含される。 In addition, the organic group can contain a heteroatom in the main chain of the organic group. The heteroatom includes an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom and the like.
さらに、前記有機基は、金属原子を含有していてもよい。この場合、金属原子としては、リチウム、ナトリウム、カリウム、ルビジウム、セシウムなどのアルカリ金属、ベリリウム、マグネシウム、カルシウム、ストロンチウム、バリウムなどのアルカリ土頚金属、ホウ素、アルミニウム、チタン、錫、鉄などの金属原子を挙げることができる。これらの金属原子は、通常、炭素−金属の結合や、イオン結合等の結合形態で有機基に含まれる。 Furthermore, the organic group may contain a metal atom. In this case, the metal atoms include alkali metals such as lithium, sodium, potassium, rubidium and cesium, alkaline earth metals such as beryllium, magnesium, calcium, strontium and barium, metals such as boron, aluminum, titanium, tin and iron Atoms can be mentioned. These metal atoms are usually contained in the organic group in a bond form such as a carbon-metal bond or an ionic bond.
本発明における含フッ素不飽和チオール誘導体の前記有機基には、さらに以下のものも包含される。
糖類としては、特に制限されるものではないが、通常は単糖類、アミノ糖、オリゴ糖類である。単糖類としてペントース、ヘキソース、デオキシヘキソース、ヘプトース、アミノ糖が挙げられ、具体的にはアラビノース、リバース、キシロース、グルコース、ガラクトース、マンノース、フルクトース、ラムノース、フコース、ジギトキソース、チマロース、オレアンドロース、ジギタロース、アピオース、ハマメロース、ストレプトース、セドヘプチュロース、コリオース、グルコサミン、ガラクトサミン、2−デオキシ−2−メチルアミノグルコースなどが例示される。オリゴ糖類としては非還元性オリゴ糖、還元性オリゴ糖が挙げられ、具体的にはショ糖、トレハロース、ゲンチアノース、ラフィノース、乳糖、セルビオース、麦芽糖、ゲンチオビオースなどが例示される。
The organic group of the fluorine-containing unsaturated thiol derivative in the present invention further includes the following.
The saccharide is not particularly limited, but is usually a monosaccharide, an amino sugar, or an oligosaccharide. Examples of monosaccharides include pentose, hexose, deoxyhexose, heptose, and amino sugar. Examples include apiose, hamamelose, streptose, sedoheptulose, coliose, glucosamine, galactosamine, 2-deoxy-2-methylaminoglucose and the like. Examples of oligosaccharides include non-reducing oligosaccharides and reducing oligosaccharides, and specific examples include sucrose, trehalose, gentianose, raffinose, lactose, cellobiose, maltose, and gentiobiose.
アミン類としては、通常含まれる化合物中の元素数は、炭素数が50以下、酸素数が20以下、窒素数が30以下、硫黄数が5以下で構成されるものであり、好ましくは、炭素数35以下、酸素数5以下、窒素数15以下、硫黄数3以下、より好ましくは、炭素数2〜20、酸素数3以下、窒素数2〜10、硫黄数1以下の範囲のものである。
As the amines, the number of elements in the compound usually contained is composed of 50 or less carbon atoms, 20 or less oxygen atoms, 30 or less nitrogen atoms, and 5 or less sulfur atoms, preferably carbon. Number 35 or less, oxygen number 5 or less,
アミノ酸類としては、具体的にはグリシン、アラニン、バリン、ロイシン、イソロイシン、セリン、トレオニン、アスパラギン酸、グルタミン酸、アスパラギン、グルタミン、リジン、オルニチン、アルギニン、ヒスチジン、ヒドロキシリジン、システイン、シスチン、メチオニン、フェニルアラニン、チロシン、トリプトファン、プロリン、4−ヒドロキシプロリン、トリコロミン酸、イボテン酸、キスカリン酸、カナバニン、カイニン酸、ドモイ酸、1−アミノシクロプロパンカルボン酸、2−(メチレンシクロプロピル)グリシン、ヒポグリシンA、3−シアノアラニン、アベナ酸、ムギネ酸、ミモシン、レボドパ、β−ヒドロキシ−γ−メチルフルタミン酸、5−ヒドロキシトリプトファン、パントテン酸、ラミニン、ベタシアニンなどが例示され、またタウリンなどのスルホン酸基を有するアミン類なども挙げられる。 Specific amino acids include glycine, alanine, valine, leucine, isoleucine, serine, threonine, aspartic acid, glutamic acid, asparagine, glutamine, lysine, ornithine, arginine, histidine, hydroxylysine, cysteine, cystine, methionine, phenylalanine. , Tyrosine, tryptophan, proline, 4-hydroxyproline, tricolominic acid, ibotenic acid, kisscaric acid, canavanine, kainic acid, domoic acid, 1-aminocyclopropanecarboxylic acid, 2- (methylenecyclopropyl) glycine, hypoglycine A, 3 -Cyanoalanine, Avenaic acid, Mugineic acid, Mimosine, Levodopa, β-hydroxy-γ-methylflutamic acid, 5-hydroxytryptophan, pantothenic acid, laminin, betacyanin Examples thereof include amines having a sulfonic acid group such as taurine.
また、前記アミン類は、ハロゲン原子で置換されていても良く、ハロゲン原子としてフッ素、塩素、臭素、ヨウ素が挙げられ、1個以上置換されていても良い。また、リン酸基とアミノアルコールが結合していろものであっても良い。アミノアルコールとしてはコリン、エタノールアミン、セリンが挙げられる。 The amines may be substituted with a halogen atom. Examples of the halogen atom include fluorine, chlorine, bromine and iodine, and one or more of them may be substituted. Further, the phosphoric acid group and the amino alcohol may be bonded. Examples of amino alcohols include choline, ethanolamine, and serine.
ペプチド類としては、特に制限されるものではないが、通常含窒素ポリマーであり、2個以上のアミノ酸による重縮合化合物またはタンパク質、ミオグロビン、ヘモグロビンなどのポリペプチド等が挙げられる。 Although it does not restrict | limit especially as peptides, Usually, it is a nitrogen-containing polymer, Polypeptides, such as a polycondensation compound or protein by 2 or more amino acids, myoglobin, hemoglobin, etc. are mentioned.
核酸としては、ヌクレオシド、ヌクレオチド、もしくはヌクレオチド単位のポリマー鎖が挙げられる。ヌクレオシドは、シトシン、チミン、アデニン、グアニンのうち塩基と2−デオキシリボースまたはリボースの糖が結合したものであり、ヌクレオチドは、ヌクレオシドの糖にリン酸基が結合したものであり、チミンはウラシルも含まれる。 Nucleic acids include nucleosides, nucleotides, or polymer chains of nucleotide units. A nucleoside is a cytosine, thymine, adenine, or guanine base linked to a 2-deoxyribose or ribose sugar, a nucleotide is a nucleoside sugar linked to a phosphate group, and a thymine is also uracil. included.
本発明の含フッ素不飽和チオール誘導体は、例えば、下記に示す合成経路などを用いて製造することができる。なお、式中のR4〜R8は、いずれも有機基を意味する。
実施例
以下、本発明について実施例を挙げて具体的に説明するが、その要旨を越えない限りこれらに限定されるものではない。図1には実施例に記載の原料から目的化合物を合成する全工程を示す。なお、実施例中の化合物番号は、全て図1に示す化合物である。
EXAMPLES Hereinafter, the present invention will be specifically described with reference to examples, but the present invention is not limited to these examples unless it exceeds the gist. FIG. 1 shows all the steps for synthesizing the target compound from the raw materials described in the Examples. In addition, all the compound numbers in an Example are the compounds shown in FIG.
(化合物1の合成)
8−ブロモオクタノールとジヒドロピランの無水塩化メチレン溶液に、氷冷下p−トルエンスルホン酸を加えた。室温で18時間攪拌した後、塩化メチレンで希釈した。これを水、飽和食塩水で順に洗浄し、無水硫酸マグネシウムで乾燥させた。ろ過後溶媒を留去し、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=5:95)で精製し、化合物1を92〜99%で得た。
(Synthesis of Compound 1)
P-Toluenesulfonic acid was added to an anhydrous methylene chloride solution of 8-bromooctanol and dihydropyran under ice cooling. After stirring at room temperature for 18 hours, it was diluted with methylene chloride. This was washed in turn with water and saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off and the residue was purified by column chromatography (silica gel, ethyl acetate: hexane = 5: 95) to obtain
(化合物2の合成)
リチウムアセチリド・エチレンジアミンの無水ジメチルスルホキシド溶液に、氷冷下、化合物1の無水ジメチルスルホキシド溶液を加えた。同温度で3時間攪拌した後、氷水を加え、ヘキサンで抽出し、その後に飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。ろ過後溶媒を留去し、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=5:95)で精製し、化合物2を65〜85%で得た。
(Synthesis of Compound 2)
An anhydrous dimethyl sulfoxide solution of
(化合物3の合成)
化合物2とペルフルオロオクチルヨーダイドのアセトニトリル水溶液に、ハイドロサルファナトリウムと炭酸水素ナトリウムを加え、室温で4時間攪拌した。これを水で希釈し、エーテルで抽出した。その後、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。ろ過後溶媒を留去し、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=5:95)で精製し、化合物3(E体とZ体の混じり)を71〜91%で得た。
(Synthesis of Compound 3)
Hydrosulfuric acid sodium and sodium hydrogencarbonate were added to an acetonitrile aqueous solution of
(化合物4の合成)
−20℃に冷却したt−ブトキシカリウムの無水ジエチルエーテル溶液に化合物3の無水ジエチルエーテル溶液を加え、同温度で1時間さらに0℃で2時間攪拌した。これを塩酸水溶液で中和し、エーテルで抽出した。その後、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。ろ過後溶媒を留去し、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=1:9)で精製し、化合物4を87〜99%で得た。
(Synthesis of Compound 4)
An anhydrous diethyl ether solution of
(化合物5の合成)
化合物4のメタノール溶液にp−トルエンスルホン酸を加え、室温で24時間攪拌した。これに水を加えた後、エーテルで抽出した。ろ過後溶媒を留去し、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=3:7)で精製し、化合物5を82〜99%で得た。
(Synthesis of Compound 5)
P-Toluenesulfonic acid was added to a methanol solution of compound 4 and stirred at room temperature for 24 hours. Water was added to this, followed by extraction with ether. After filtration, the solvent was distilled off and the residue was purified by column chromatography (silica gel, ethyl acetate: hexane = 3: 7) to obtain Compound 5 at 82 to 99%.
(化合物6の合成)
化合物5の無水テトラヒドロフラン溶液に、四臭化炭素とトリフェニルホスフィンを加え、室温で2時間攪拌した。これを減圧下に濃縮した後、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=5:95)で精製し、化合物6を67〜87%で得た。
(Synthesis of Compound 6)
Carbon tetrabromide and triphenylphosphine were added to an anhydrous tetrahydrofuran solution of compound 5, and the mixture was stirred at room temperature for 2 hours. This was concentrated under reduced pressure and then purified by column chromatography (silica gel, ethyl acetate: hexane = 5: 95) to obtain
(化合物7の合成)
チオ酢酸カリウムの無水N,N−ジメチルホルムアミド溶液に化合物6のN,N−ジメチルホルムアミド溶液を滴下し、室温で18時間攪拌した。これに氷水を加え、塩化メチレンで抽出した。ろ過後溶媒を留去し、化合物7を80〜95%で得た。
(Synthesis of Compound 7)
To an anhydrous N, N-dimethylformamide solution of potassium thioacetate, an N, N-dimethylformamide solution of
化合物7について、1Hまたは19F−NMRスペクトルにより同定した。
1H−NMR(TMS、CDCl3):1.28−1.47(m、8H)、1.50−1.64(m、4H)、2.32(s、3H)、2.35(m、2H)、2.87(t、J=7.3Hz、2H)。
19F−NMR(CFCl3、CDCl3):−80.64(t、J=9.71Hz、3F)、−95.58(m、2F)、−120.49(m、2F)、−121.88(m、4F)、−122.65(m、4F)、−126.03(m、2F)。
1H-NMR (TMS, CDCl3): 1.28-1.47 (m, 8H), 1.50-1.64 (m, 4H), 2.32 (s, 3H), 2.35 (m, 2H), 2.87 (t, J = 7.3 Hz, 2H).
19F-NMR (CFCl 3 , CDCl 3 ): −80.64 (t, J = 9.71 Hz, 3F), −95.58 (m, 2F), −120.49 (m, 2F), −121.88 (M, 4F), -122.65 (m, 4F), -126.03 (m, 2F).
(化合物8の合成)
化合物7のアセトン溶液に30%水酸化ナトリウム水溶液を滴下し、室温で2時間攪拌した。これを10%塩酸水溶液で中和し、塩化メチレンで抽出した。ろ過後溶媒を留去し、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=3:7)により精製し、化合物8を80〜95%で得た。この反応式を魏に示す。
(Synthesis of Compound 8)
A 30% aqueous sodium hydroxide solution was added dropwise to the acetone solution of
得られた化合物8を、1Hまたは19F−NMRスペクトルにより同定した。
1H−NMR(TMS、CDCl3):1.28−1.47(m、9H)、1.50−1.64(m、4H)、2.35(m、2H)、2.50(t、J=7.5Hz、2H)。
19F−NMR(CFCl3、CDCl3):−80.64(t、J=9.71Hz、3F)、−95.58(m、2F)、−120.49(m、2F)、−121.88(m、4F)、−122.55〜−122.74(m、4F)、−126.03(m、2F)。
The resulting
1H-NMR (TMS, CDCl3): 1.28-1.47 (m, 9H), 1.50-1.64 (m, 4H), 2.35 (m, 2H), 2.50 (t, J = 7.5 Hz, 2H).
19F-NMR (CFCl 3 , CDCl 3 ): −80.64 (t, J = 9.71 Hz, 3F), −95.58 (m, 2F), −120.49 (m, 2F), −121.88 (M, 4F), -122.55 to -122.74 (m, 4F), -126.03 (m, 2F).
(化合物9の合成)
化合物6をエタノールに溶解させ、これに70%水硫化ナトリウムを加え、アルゴン置換した後、50〜55℃で9時間超音波処理を行った。生成した反応溶液を塩化メチレンで希釈し、希塩酸で酸性とした後、塩化メチレンで抽出し、無水硫酸マグネシウムで乾燥させた。ろ過後溶媒を留去し、カラムロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=1:1)により精製し,化合物8と9を、それぞれ34〜54%と22〜44%で得た。
(Synthesis of Compound 9)
得られた化合物9は、1Hまたは19F−NMRスペクトルにより同定した。
1H−NMR(TMS、CDCl3):1.28−1.47(m、16H)、1.50−1.64(m、8H)、2.35(m、4H)、2.68(t、J=7.5Hz、4H)。
19F−NMR(CFCl3、CDCl3):−80.64(t、J=9.71Hz、6F)、−95.58(m、4F)、−120.49(m、4F)、−121.88(m、8F)、−122.55〜−122.74(m、8F)、−126.03(m、4F)。
The obtained compound 9 was identified by 1H or 19 F-NMR spectrum.
1H-NMR (TMS, CDCl3): 1.28-1.47 (m, 16H), 1.50-1.64 (m, 8H), 2.35 (m, 4H), 2.68 (t, J = 7.5 Hz, 4H).
19F-NMR (CFCl 3 , CDCl 3 ): −80.64 (t, J = 9.71 Hz, 6F), −95.58 (m, 4F), −120.49 (m, 4F), −121.88 (M, 8F), -122.55 to -122.74 (m, 8F), -126.03 (m, 4F).
(化合物10の合成)
化合物3(E体とZ体の混合物)をフラッシュカラムクロマトグラフィーで3E(化合物3のE体)と3Z(化合物3のZ体)に分離し、以下の操作を行った。
−78℃に冷却した化合物3Eの無水テトラヒドロフラン溶液に1.6Mのn−ブチルリチウムのヘキサン溶液(4〜5当量)を加えた。1時間後、メタノールを加え、0℃までゆっくりと温度を上昇させた後、飽和塩化アンモニウム水溶液を加え酢酸エチルで抽出し、飽和食塩水で洗浄した後、無水硫酸マグネシウムで乾燥させた。濾過後,減圧下溶媒を留去し、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=15:85)で精製し、化合物10を71〜91%で得た。
(Synthesis of Compound 10)
Compound 3 (mixture of E-form and Z-form) was separated into 3E (E-form of Compound 3) and 3Z (Z-form of Compound 3) by flash column chromatography, and the following operation was performed.
A 1.6 M n-butyllithium hexane solution (4 to 5 equivalents) was added to an anhydrous tetrahydrofuran solution of compound 3E cooled to -78 ° C. After 1 hour, methanol was added and the temperature was slowly raised to 0 ° C., then a saturated aqueous ammonium chloride solution was added, the mixture was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the residue was purified by column chromatography (silica gel, ethyl acetate: hexane = 15: 85) to obtain
(化合物11の合成)
化合物10の無水テトラヒドロフラン溶液に四臭化炭素とトリフェニルホスフィンを加え、室温で2時間攪拌した。これを減圧下に濃縮した後、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=5:95)で精製し、化合物11を70〜90%で得た。
(Synthesis of Compound 11)
Carbon tetrabromide and triphenylphosphine were added to an anhydrous tetrahydrofuran solution of
(化合物12の合成)
チオ酢酸カリウムの無水N,N−ジメチルホルムアミド溶液に化合物11の無水N,N−ジメチルホルムアミド溶液を滴下し、室温で18時間攪拌した。これに氷水を加え、塩化メチレンで抽出した。ろ過後溶媒を留去し、化合物12を78〜98%で得た。
(Synthesis of Compound 12)
An anhydrous N, N-dimethylformamide solution of
化合物12について、1Hまたは19F−NMRスペクトルにより同定した。
1H−NMR(TMS、CDCl3):1.20−1.50(m、10H)、1.52−1.63(m、2H)、2.25−2.37(m、2H)、2.32(s、3H)、2.87(t、J=6.5Hz、2H)、5.48(dd、J=15.4、12.8Hz、1H)、6.11(dtt、J=11.9、7.8、2.Hz、1H)。
19F−NMR(CFCl3、CDCl3):−80.66(t、J=10.04Hz、3F)、−106.54(m、2F)、−121.35(m、2F)、−121.90(m、4F)、−122.65(m、2F)、−123.50(m、2F)、−126.06(m、2F)。
1H-NMR (TMS, CDCl3): 1.20-1.50 (m, 10H), 1.52-1.63 (m, 2H), 2.25-2.37 (m, 2H); 32 (s, 3H), 2.87 (t, J = 6.5 Hz, 2H), 5.48 (dd, J = 15.4, 12.8 Hz, 1H), 6.11 (dtt, J = 11 .9, 7.8, 2.Hz, 1H).
19F-NMR (CFCl 3 , CDCl 3 ): −80.66 (t, J = 10.04 Hz, 3F), −106.54 (m, 2F), −121.35 (m, 2F), −121.90 (M, 4F), -122.65 (m, 2F), -123.50 (m, 2F), -126.06 (m, 2F).
(化合物13の合成)
化合物12のアセトン溶液に30%水酸化ナトリウム水溶液を滴下し、室温で2時間攪拌した。これを10%塩酸水溶液で中和し、塩化メチレンで抽出した。ろ過後溶媒を留去し、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=3:7)により精製し、化合物13を80〜95%で得た。
(Synthesis of Compound 13)
A 30% aqueous sodium hydroxide solution was added dropwise to the acetone solution of
得られた生成物13は、1Hまたは19F−NMRスペクトルにより同定した。
1H−NMR(TMS、CDCl3):1.20−1.50(m、11H)、1.52−1.63(m、2H)、2.35(m、2H)、2.50(t、J=7.5Hz、2H)、5.48(dd、J=15.4、12.8Hz、1H)、6.11(dtt、J=11.9、7.8、2.Hz、1H)。
19F−NMR(CFCl3、CDCl3):−80.66(t、J=10.04Hz、3F)、−106.54(m、2F)、−121.35(m、2F)、−121.90(m、4F)、−122.65(m、2F)、−123.50(m、2F)、−126.06(m、2F)。
The resulting
1H-NMR (TMS, CDCl3): 1.20-1.50 (m, 11H), 1.52-1.63 (m, 2H), 2.35 (m, 2H), 2.50 (t, J = 7.5 Hz, 2H), 5.48 (dd, J = 15.4, 12.8 Hz, 1H), 6.11 (dtt, J = 11.9, 7.8, 2.Hz, 1H) .
19F-NMR (CFCl 3 , CDCl 3 ): −80.66 (t, J = 10.04 Hz, 3F), −106.54 (m, 2F), −121.35 (m, 2F), −121.90 (M, 4F), -122.65 (m, 2F), -123.50 (m, 2F), -126.06 (m, 2F).
(化合物14の合成)
化合物11をエタノールに溶解させ、これに70%水硫化ナトリウムを加え、アルゴン置換した後,50〜55℃で9時間超音波処理を行った。生成した反応溶液を塩化メチレンで希釈し、希塩酸で酸性とした後、塩化メチレンで抽出し、無水硫酸マグネシウムで乾燥させた。ろ過後溶媒を留去し、カラムロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=1:1)により精製し,化合物13と14を、それぞれ35〜55%と2〜45%で得た。
(Synthesis of Compound 14)
得られた生成物14は、1Hまたは19F−NMRスペクトルにより同定した。
1H−NMR(TMS、CDCl3):1.20−1.50(m、10H)、1.52−1.63(m、2H)、2.35(m、2H)、2.50(t、J=7.5Hz、2H)、5.48(dd、J=15.4、12.8Hz、1H)、6.11(dtt、J=11.9、7.8、2.Hz、1H)。
19F−NMR(CFCl3、CDCl3):−80.66(t、J=10.04Hz、3F)、−106.54(m、2F)、−121.35(m、2F)、−121.90(m、4F)、−122.65(m、2F)、−123.50(m、2F)、−126.06(m、2F)。
The resulting
1H-NMR (TMS, CDCl3): 1.20-1.50 (m, 10H), 1.52-1.63 (m, 2H), 2.35 (m, 2H), 2.50 (t, J = 7.5 Hz, 2H), 5.48 (dd, J = 15.4, 12.8 Hz, 1H), 6.11 (dtt, J = 11.9, 7.8, 2.Hz, 1H) .
19F-NMR (CFCl 3 , CDCl 3 ): −80.66 (t, J = 10.04 Hz, 3F), −106.54 (m, 2F), −121.35 (m, 2F), −121.90 (M, 4F), -122.65 (m, 2F), -123.50 (m, 2F), -126.06 (m, 2F).
(化合物15の合成)
化合物5のトルエン溶液に当量の酢酸と無水酢酸とトリフェニルホスフィン、触媒量のビスベンジリデンアセトンパラジウムを順に加え、110℃で15時間加熱した。溶媒留去後、カラムロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=5:95)により精製し,化合物15を55〜85%で得た。
(Synthesis of Compound 15)
An equivalent amount of acetic acid, acetic anhydride, triphenylphosphine, and a catalytic amount of bisbenzylideneacetone palladium were sequentially added to a toluene solution of Compound 5, and the mixture was heated at 110 ° C. for 15 hours. After the solvent was distilled off, the residue was purified by column chromatography (silica gel, ethyl acetate: hexane = 5: 95) to obtain
(化合物16の合成)
化合物15のテトラヒドロフラン溶液に10%水酸化ナトリウム水溶液を加え、室温で1日攪拌した。これを中和させた後、塩化メチレンで抽出し、飽和食塩水で洗浄し、無水硫酸マグネシウムで乾燥させた。濾過溶媒留去を留去し、カラムロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=10:90)により精製し,化合物16を75〜95%で得た。
(Synthesis of Compound 16)
To a tetrahydrofuran solution of
(化合物17の合成)
化合物16の無水テトラヒドロフラン溶液に四臭化炭素とトリフェニルホスフィンを加え、室温で2時間攪拌した。これを減圧下に濃縮した後、カラムクロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=5:95)で精製し、化合物17を65〜85%で得た。
(Synthesis of Compound 17)
Carbon tetrabromide and triphenylphosphine were added to an anhydrous tetrahydrofuran solution of compound 16, and the mixture was stirred at room temperature for 2 hours. This was concentrated under reduced pressure, and then purified by column chromatography (silica gel, ethyl acetate: hexane = 5: 95) to obtain
(化合物18及び19の合成)
化合物17をエタノールに溶解させ、これに70%水硫化ナトリウムを加え、アルゴン置換した後,50〜55℃で9時間超音波処理を行った。生成した反応溶液を塩化メチレンで希釈し、希塩酸で酸性とした後、塩化メチレンで抽出し、無水硫酸マグネシウムで乾燥させた。ろ過後溶媒を留去し、カラムロマトグラフィー(シリカゲル、酢酸エチル:ヘキサン=1:1)により精製し,化合物18及び19を、それぞれ30〜55%及び20〜45%で得た。
(Synthesis of
得られた生成物18及び19は、1Hまたは19F−NMRスペクトルにより同定した。
化合物18:
1H−NMR(TMS、CDCl3):1.25−1.31(m、7H)、1.52−1.53(m、2H)、2.50(t、J=7.5Hz、2H)、3.92(t、J=6.5Hz、2H)、5.62(dt、J=15.0、6.5Hz、1H)、6.08(dd、J=15.0、9.8Hz、1H)、6.75(ddt、J=15.4、9.8、2.0Hz、1H)、7.05−7.20(m、1H)。
19F−NMR(CFCl3、CDCl3):−80.64(t、J=9.71Hz、3F)、−111.88(m、2F)、−121.31(m、2F)、−121.80(m、4F)、−122.60(m、2F)、−123.27(m、2F)、−125.97(m、2F)。
化合物19:
1H−NMR(TMS、CDCl3):1.25−1.31(m、12H)、1.52−1.53(m、4H)、2.68(t、J=7.5Hz、4H)、3.92(t、J=6.5Hz、4H)、5.62(dt、J=15.0、6.5Hz、2H)、6.08(dd、J=15.0、9.8Hz、2H)、6.75(ddt、J=15.4、9.8、2.0Hz、2H)、7.05−7.20(m、2H)。
19F−NMR(CFCl3、CDCl3):−80.64(t、J=9.71Hz、6F)、−111.88(m、4F)、−121.31(m、4F)、−121.80(m、8F)、−122.60(m、4F)、−123.27(m、4F)、−125.97(m、4F)。
The resulting
Compound 18:
1H-NMR (TMS, CDCl3): 1.25-1.31 (m, 7H), 1.52-1.53 (m, 2H), 2.50 (t, J = 7.5 Hz, 2H), 3.92 (t, J = 6.5 Hz, 2H), 5.62 (dt, J = 15.0, 6.5 Hz, 1H), 6.08 (dd, J = 15.0, 9.8 Hz) 1H), 6.75 (ddt, J = 15.4, 9.8, 2.0 Hz, 1H), 7.05-7.20 (m, 1H).
19F-NMR (CFCl 3 , CDCl 3 ): −80.64 (t, J = 9.71 Hz, 3F), −111.88 (m, 2F), −121.31 (m, 2F), −121.80 (M, 4F), -122.60 (m, 2F), -123.27 (m, 2F), -125.97 (m, 2F).
Compound 19:
1H-NMR (TMS, CDCl3): 1.25-1.31 (m, 12H), 1.52-1.53 (m, 4H), 2.68 (t, J = 7.5 Hz, 4H), 3.92 (t, J = 6.5 Hz, 4H), 5.62 (dt, J = 15.0, 6.5 Hz, 2H), 6.08 (dd, J = 15.0, 9.8 Hz) 2H), 6.75 (ddt, J = 15.4, 9.8, 2.0 Hz, 2H), 7.05-7.20 (m, 2H).
19F-NMR (CFCl 3 , CDCl 3 ): −80.64 (t, J = 9.71 Hz, 6F), −111.88 (m, 4F), −121.31 (m, 4F), −121.80 (M, 8F), -122.60 (m, 4F), -123.27 (m, 4F), -125.97 (m, 4F).
本発明で得られる含フッ素不飽和チオール誘導体は、良好な界面活性能を有することから、化粧品、農薬、工業薬品、家庭用品などの広範な分野に幅広く利用できるものである。 Since the fluorine-containing unsaturated thiol derivative obtained in the present invention has a good surface activity, it can be widely used in a wide range of fields such as cosmetics, agricultural chemicals, industrial chemicals and household products.
Claims (1)
R1-X-R2 (1)
R1-X-R3-S-S-R3-X-R1 (2)
[式中、R 1 は炭素数2〜25のパーフルオロアルキル基を、R 2 はSHを有する炭素数2〜25のアルキル基を、R 3 は炭素数2〜25のアルキレン基を、Xは、C≡Cまたは(CH=CH) n (ただし、n=2である。)を示す。]で表される含フッ素不飽和チオール誘導体。 The following general formula (1) or (2)
R 1 -XR 2 (1)
R 1 -XR 3 -SSR 3 -XR 1 (2)
[Wherein R 1 represents a perfluoroalkyl group having 2 to 25 carbon atoms, R 2 represents an alkyl group having 2 to 25 carbon atoms having SH, R 3 represents an alkylene group having 2 to 25 carbon atoms, and X represents , C≡C or (CH═CH) n (where n = 2). ] The fluorine-containing unsaturated thiol derivative represented by this.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004048437A JP4300293B2 (en) | 2004-02-24 | 2004-02-24 | Fluorine-containing unsaturated thiol derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004048437A JP4300293B2 (en) | 2004-02-24 | 2004-02-24 | Fluorine-containing unsaturated thiol derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005239582A JP2005239582A (en) | 2005-09-08 |
JP4300293B2 true JP4300293B2 (en) | 2009-07-22 |
Family
ID=35021700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004048437A Expired - Lifetime JP4300293B2 (en) | 2004-02-24 | 2004-02-24 | Fluorine-containing unsaturated thiol derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4300293B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7143748B2 (en) * | 2018-12-07 | 2022-09-29 | 株式会社豊田中央研究所 | Vehicle driving device with steering function |
JP7321904B2 (en) | 2019-04-18 | 2023-08-07 | 東ソー・ファインケム株式会社 | Fluorine-containing organic sulfur compound and surface modifier using the same |
-
2004
- 2004-02-24 JP JP2004048437A patent/JP4300293B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2005239582A (en) | 2005-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2264824C (en) | A process for preparing 2-amino malonic acid derivatives and 2-amino-1,3-propanediol derivatives, and intermediates for preparing the same | |
US8058412B2 (en) | Dehydroxyfluorination agent | |
WO2015106624A1 (en) | 2,4(1h,3h)-pyrimidinedione derivatives and preparation method therefor | |
Muzard et al. | Fluorinated ketene dithioacetals. 2. Synthesis of 2-hydroperfluoro acid derivatives from perfluoroketene dithioacetals | |
US11407704B2 (en) | Process of vitamin K2 derivatives preparation | |
JP5603169B2 (en) | (E) Process for producing 3-methyl-2-cyclopentadecenone | |
BE897516A (en) | NOVEL DEOXYURIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | |
JP4300293B2 (en) | Fluorine-containing unsaturated thiol derivative | |
CN105968040A (en) | Preparation method of ledipasvir intermediate | |
JP2024517260A (en) | Synthesis process of nicotinamide riboside chloride (NRCL) | |
Zhou et al. | A new alkylation–elimination method for synthesis of antiviral fluoromethylenecyclopropane analogues of nucleosides | |
JP2004075586A (en) | Cyclic ester compound | |
US6900298B2 (en) | Process for producing nucleic acid derivative | |
JP4610252B2 (en) | Method for producing 4-fluoroproline derivative | |
JP2004002215A (en) | Method for producing sphingolipid derivative | |
EP0601918A1 (en) | Process for the preparation of vitamin A and intermediates useful in this process | |
JP7482701B2 (en) | Difluoromethylene compounds and their production methods | |
JP2004244388A (en) | Sphingolipid derivative | |
BE897434A (en) | PROCESS FOR THE PREPARATION OF 5 - E) - (2-BROMOVINYL) -2'-DESOXYURIDINE AND ITS DERIVATIVES AND DERIVATIVES OF 5- (E) - (2-BROMOVINYL) -2'-DEXOXYURIDINE | |
JP4446063B2 (en) | Fluorine-containing polyacetylene derivative | |
JP4189485B2 (en) | Cyclic amide compound | |
Yamazaki et al. | Lewis acid-promoted reactions of ethenetricarboxylates with γ-CF3-substituted propargyl alcohols | |
JP2005060326A (en) | Pseudocyclic amide compound and lipid nanotube | |
JP2005239680A (en) | Fluorine-containing unsaturated lipid derivative | |
JP2673478B2 (en) | Ceramide derivative, its production method and intermediate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051004 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081209 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090126 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090224 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090303 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090324 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |